MAIA Biotechnology, Inc. (MAIA) Raises $695K in Private Placement to Advance Cancer Trial
MAIA Biotechnology, Inc. (NYSE:MAIA), a clinical-stage biopharmaceutical company, has announced a private placement agreement to raise approximately $695,000.
Maia Biotechnology Inc. (MAIA)
Market is closed
Sector: Pharmaceutical Preparations
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Solas Capital Management Frederick Tucker Golden | 3,030,845 | $4,364,417 | -30% | 2.34% |
| 2. | Alyeska Investment Group Anand Parekh | 2,500,000 | $3,600,000 | 0.01% | |
| 3. | 683 Capital Partners Ari Zweiman | 1,066,666 | $1,535,999 | 0.08% | |
| 4. | Renaissance Technologies Jim Simons | 415,700 | $598,608 | 0% | |
| 5. | Citadel Investment Group Ken Griffin | 24,890 | $35,842 | 0% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $1.37 | 73,000 | $100,010.00 | 1,049,121 | 2026-09-14 | Filing | |
| $1.32 | 37,595 | $49,516.37 | 773,296 | 2026-09-10 | Filing | |
| $1.35 | 46,620 | $62,937.00 | 735,701 | 2026-08-28 | Filing | |
| $1.39 | 78,239 | $108,752.21 | 689,081 | 2026-08-27 | Filing | |
| $1.39 | 8,931 | $12,414.09 | 610,842 | 2026-08-26 | Filing |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 2,413,270 | $3,475,109 | 0% | |
| 2. | 796,723 | $1,107,445 | 0.17% | |
| 3. | 514,583 | $741,000 | 0.02% | |
| 4. | 504,380 | $726,568 | 0% | |
| 5. | 500,000 | $720,000 | 0.13% |
News See All
Hedge Fund Resource Center